Latest pharmaceutical industry Stories
Indian Government to grant trial waiver for Orphan Drugs if certain criteria are met RESEARCH TRIANGLE PARK, N.C., March 31, 2015 /PRNewswire/ -- Dr.
Industry Transitions as New Law Takes Effect TEMPLE, Texas, March 31, 2015 /PRNewswire/ -- Unique Pharmaceuticals,
QUÉBEC CITY, March 31, 2015 /PRNewswire/ - Aeterna Zentaris Inc.
BARCELONA, Spain, March 31, 2015 /PRNewswire/ -- More than 50 life sciences organisations move to Veeva Vault eTMF for complete access, visibility, and control of TMF content
SAN DIEGO, March 31, 2015 /PRNewswire/ -- Ajinomoto Althea, Inc.
The recently implemented GAIN Act is expected to lure companies back into R&D as well as attract new participants, finds Frost & Sullivan LONDON, March 31, 2015 /PRNewswire/ -- The
In two days, two of the industry's top inspectional readiness professionals will lead attendees through all aspects of the inspections process.
CUPERTINO, Calif., March 30, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has initiated a multi-dose Phase 1 clinical trial of an oral formulation of DUR-928,
- Chimeric Antigen Receptor T-cell (CAR-T) therapy enhances Merck Serono's R&D technology portfolio in immuno-oncology GERMANTOWN, Md., March 30, 2015 /PRNewswire/ --
- Large; stout; burly.